SCM
SRPT icon

Silverarc Capital Management’s Sarepta Therapeutics SRPT Stock Holding History

Silverarc Capital Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-51,245
Closed -$6.4M – 81
2024
Q3 		$6.4M Buy
51,245
+9,245
+22% +$1.28M 1.44% 23
2024
Q2 		$6.64M Buy
+42,000
New +$5.4M 1.64% 21
2024
Q1 		– Sell
-46,884
Closed -$4.52M – 96
2023
Q4 		$4.52M Buy
46,884
+37,687
+410% +$3.62M 1.39% 33
2023
Q3 		$1.11M Sell
9,197
-20,663
-69% -$2.34M 0.42% 57
2023
Q2 		$3.42M Buy
29,860
+20,590
+222% +$2.66M 1.15% 32
2023
Q1 		$1.28M Buy
+9,270
New +$1.2M 0.57% 55

Other funds holding SRPT

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return